About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

FemBloc® Permanent Contraception - Early Pivotal Trial

NCT03433911·12 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Femasys Inc.

Age

21–45

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

Female, 21 - 45 years of age desiring permanent birth control
Sexually active with male partner
For FemBloc Arm:
* Regular menstrual cycle for last 3 months or on hormonal contraceptives
For Control Arm:
* Undergoing planned laparoscopic bilateral tubal sterilization

You may not be if

Uncertainty about the desire to end fertility
Known or suspected pregnancy
Prior tubal surgery, including sterilization attempt
Prior endometrial ablation
Presence, suspicion, or previous history of gynecologic malignancy
Abnormal uterine bleeding requiring evaluation or treatment
Scheduled to undergo concomitant intrauterine procedures at the time of procedure(s)

The record

StatusCompleted

PhaseNo phase

Taking part240

StartedFeb 2018

UpdatedFeb 27, 2026

Conditions

Where12

New Horizons Clinical Trials
Chandler, Arizona, United States
Stanford University
Stanford, California, United States
Altus Research Inc.
Lake Worth, Florida, United States

Clareo Health | FemBloc® Permanent Contraception - Early Pivotal Trial